Features
Piperacillin/Tazobactam Kabi is an intravenous antibiotic combination containing the extended-spectrum penicillin piperacillin and the beta-lactamase inhibitor tazobactam, which broadens the spectrum of piperacillin by making it effective against organisms which express beta-lactamase and would normally degrade piperacillin.
- Broad spectrum activity against many Gram-positive, Gram-negative, aerobic and anaerobic pathogen